Evidence map›Paper›PMID 32292362›Full record

ArticleFrontiers in psychiatry2020

Elevated Plasma Reelin Levels in Children With Autism.

Inmaculada Cuchillo-Ibáñez, Patricia Andreo-Lillo, Lorena Pastor-Ferrándiz, Francisco Carratalá-Marco, Javier Sáez-Valero

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?International journal of molecular sciences · 2022
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Inmaculada Cuchillo-IbáñezInstituto de Neurociencias de Alicante, Department of Molecular Neurobiology and Neuropathology, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain.
Patricia Andreo-LilloNeuropediatric Unit, Pediatric Department, University Hospital of Sant Joan d'Alacant, Sant Joan d'Alacant, Spain.
Lorena Pastor-FerrándizNeuropediatric Unit, Pediatric Department, University Hospital of Sant Joan d'Alacant, Sant Joan d'Alacant, Spain.
Francisco Carratalá-MarcoNeuropediatric Unit, Pediatric Department, University Hospital of Sant Joan d'Alacant, Sant Joan d'Alacant, Spain.
Javier Sáez-ValeroInstituto de Neurociencias de Alicante, Department of Molecular Neurobiology and Neuropathology, Universidad Miguel Hernández-CSIC, Sant Joan d'Alacant, Spain.
Hospital Universitari Sant Joan D'Alacant · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders involving age-dependent gene dysregulation. Reelin is a glycoprotein that varies its expression throughout lifetime and controls cortical patterning and synaptogenesis. Brain and plasma reelin levels have been reported to be low in adults with autism; as well as in children with autism, but only when compared to control adults. Therefore, reelin expression levels in children with autism are unclear. For this reason, we compared plasma reelin levels in children with autism and children without autism (non-ASD) of similar ages to evaluate reelin expression in ASD during childhood. Plasma samples from 19 non-ASD (8.9 ± 0.8 years) and 40 children with autism (7.5 ± 0.5 years) were analyzed. We found that 50% of the children with autism displayed similar plasma reelin levels to the non-ASD group. However, the remaining 50% expressed more than 30 times more reelin compared to non-ASD levels. We also show that male children with autism displayed significantly higher reelin levels than females. The clinical presentation of this subgroup could not be distinguished from that of children with autism. Epilepsy or attention-deficit/hyperactivity disorder (ADHD) was not associated to reelin levels. We conclude that the high levels of plasma reelin might be an important hallmark in a subset of children with autism, previously unnoticed. As we could not find any correlation between reelin levels and ASD clinical presentations, our results may indicate transient reelin increases in the plasma or the characterization of a group of ASD individuals with a different pathophysiology.

Indexed as

autismchildrendimersenzyme-linked immunosorbent assayoligomersreelinWestern blotting

Identifiers

PMID32292362
PMCPMC7135852
OpenAlexW3015076709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.